What does the evidence say about Ginger Cycling Performance Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Ginger Cycling Performance Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Risk of bias was assessed using RoB 2 (randomized trials) and the Joanna Briggs Institute quasi-experimental tool. [Trybulski R (2026); evidence level 1] - Interleukin 6 most consistently increased after exercise, whereas tumor necrosis factor alpha, interleukin 10, and other mediators showed mixed or context-dependent changes. [Trybulski R (2026); evidence level 1] - Risk of bias was commonly rated as some concerns, with frequent limitations in pre-analytical control and reporting. [Trybulski R (2026); evidence level 1] - High-intensity intermittent exercise can acutely alter circulating cytokines, but findings are heterogeneous. [Trybulski R (2026); evidence level 1] - Protein intake per kg body mass predicted performance time in the placebo trial and average VO 2 in the ginger trial; other macronutrients were not associated with outcomes. [Kurtz JA (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.